Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals

Journal of Chemotherapy

Volumn 23, Issue 1, 2011, Pages 13-16

  Al Sweih, N A ^a   Al Hubail, M A ^a   Rotimi, V O ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Acinetobacter spp.; Colistin; Kuwait; Resistance; Tigecycline

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MINOCYCLINE; THIENAMYCIN DERIVATIVE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER INFECTION; ACINETOBACTER JOHNSONII; ACINETOBACTER JUNII; ACINETOBACTER LWOFFII; ACINETOBACTER RADIORESISTENS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; EPSILOMETER TEST; HUMAN; KUWAIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; DRUG EFFECT; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS; HUMANS; IMIPENEM; KUWAIT; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; THIENAMYCINS;

EID: 79960413495     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2011.23.1.13     Document Type: Article

References (27)

1. Munoz- Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008; 358 (12): 1271-1281.
2. Abbo A, Navon-Venezia S, Hammer-Munz O, Krichali T, Siegmanlgra Y, Carmeli Y. Multidrug-resistant Acinetobacter baunannii. Emerg Infec Dis 2005; 11 (1): 22-29.
3. Foumier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42 (5): 692-699
4. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12 (9): 826-836.
5. Jamal W, Salama M, Dehrab N, Al-Hashem G, Shahin M, Rotimi VO. Role of tigecycline in the control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 2009; 72 (3): 233-241.
6. Capone A, D Arezzo S, Visca P, Petrosillo N, Gruppo Romano Acinetobacter baumannii. In vitro activity of tigecycline against multidrug- resistant Acinetobacter baumannii. J Antimicrob Chemother 2008; 62 (2): 422-423
7. KO KS, Suh JY, Kwon KT, Jung SI, Park KH, Kang CI et al. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007; 60 (5): 1163-1167.
8. Héritier C, Poirel L, Fournier P, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49 (10): 4174-4179.
9. Clinical and Laboratory Standards Institute/ NCCLS. Performance standards for antimicrobial susceptibility testing: Nineteenth informational supplement document M100-S19. CLSI, Wayne, PA. 2009.
10. Webb R, Healy M. Acinetobacter species identification and strain differentiation using the Diversilab system. Abstract presented at 8th annual meeting of Association for Molecular Pathology (AMP) 2002, Dallas, Texas, November 14-17. Abstract no. P129.
11. Bosshard PP, Zbinden R, Abels S, Bodinghous B, Altwegg M, Bottger EC. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 2006; 44 (4): 1359-1366.
12. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51- like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44 (8): 2974-2976.
13. Jamal WY, Al-Hashem G, Khodakhast F, Rotimi VO. Comparative in vitro activity of tigecycline and nine other antibiotics against Gram-negative bacterial isolates, including ESBL-producing strains. J Chemother 2009; 21 (3): 261-266.
14. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the car- bapenemase OXA-40. Antimicrob Agents Chemother 2006; 50 (9): 2941-2945.
15. Tan TY, Ng LS. Susceptibility of Multi-resistant Gram-negative bacilli in Singapore to tigecycline as tested by agar dilution. Ann Acad Med Singa pore 2007; 36 (10): 807-810.
16. Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC et al. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. Inter J Antimicrob Agents 2008; 32 Suppl 3: S188-191.
17. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007; 59 (4): 772-774.
18. Curcio D, Fernandez F, Jones RN, Ferraro MJ, Reller LB, Schreck- enberger PC et al. Tigecycline disk diffusion breakpoints of Acinetobacter spp: a clinical point of view. J Clin Microbiol 2007; 45 (6): 2095-2096.
19. Thamlikitkul V, Tiengrim S, Tribuddharat C. Comment on: High tige- cycline resistance in multidrug-resistant Acinetobacter baumannii. J An- timicrob Chemother 2007; 60 (1): 177-178.
20. D'Amato RF, Thornsberry C, Baker CN, Kirven LA. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetra- cycline, gentamicin, polymyxin B and carbenicillin. Antimicrob Agents Chemother 1975; 596-600.
21. Fernandez-Mazarrasa C, Mazarrasa O, Calvo J, Del Arco A, Martinez- Martinez L. High concentration of manganese in Mueller-hinton agar in- crease MICs of tigecycline determined by Etest. J Clin Microbiol 2009; 47: 827-829.
22. Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S et al. Distribution of 16SrRNA methylases among different species of Gram-negative bacilli with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect Dis 2010; Published online: 08 July 2010
23. Rahbar M, Mehrgan H, Aliakbari NH. Prevalence of antibiotic-resistant Acinetobacter baumannii in 1000-bed tertiary care hospital in Tehran, Iran. Indian J Pathol Microbiol 2010; 53: 290-293.
24. Uma Karthika R, Srinivasa Rao R, Sahoo S, Shashikala P, Kanungo R, Jayachandran S et al. Phenotypic and genotypic assays for detecting the prevalence of metallo-f3-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J Med Microbiol 2009; 58: 430-435.
25. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R on behalf of the BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative gram-negative bacteria from bacteraemias in the UK and Ireland 2001-06. J Chemother 2008; 62 suppl2: ii55-ii63
26. Ben Othman A, Zribi M, Masmoudi A, Abdellatif S, Ben lakhal S, Fendri C. Phenotypic and molecular epidemiology of Acinetobacter bau- mannii strains isolated in Rabta Hospital, Tunisia. Arch Inst Pasteur Tunis 2007; 84: 11-19.
27. Dizbay M, Tunccan OG, Sezer BE, Hizel K. Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors. Scand J Infect Dis 2010 May 26. Early Online, 1-6.